Routes of Administration: Topical Preparations Flashcards

1
Q

Describe topical drug delivery.

A
  • Administered on tissue surface.
  • Treatment of a local condition.
  • Site of administration is site of therapeutic action.
  • Minimise systemic absorption to minimise side effects.
  • Commonly skin (cutaneous/transcutaneous), but could refer to other tissue.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is an ointment?

A

Drug dissolved or dispersed in a greasy base

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the features of ointments.

A
  • Occlusive: promotes skin hydration by minimising trans epidermal water loss
  • Can be difficult to spread
  • patient acceptability could be low
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a cream?

A
  • Semi-solid emulsion
  • Multiphase dispersion of oil in water or water in oil
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the advantages of creams?

A
  • Longer residence time than lotion
  • Mixable with skin secretions , easily washable
  • Excellent patient acceptability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a gel?

A
  • Semi-solid or viscous liquid, often clear or transparent
  • Polymer network interpenetrated by a liquid
  • Mostly aqueous: hydrogels or hydro-alcoholic gels
  • Drug dissolved or dispersed in liquid component
  • May form occlusive film on skin when dried
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a lotion?

A
  • Typically water-based, thus non-occlusive:
  • Solution, suspension or emulsion.
  • Primarily used for cleansing or disinfection.
  • High spreadability: ideal for covering large area thinly.
  • Suitable for administration on hairy skin.
  • Short residence time: increasing viscosity prolongs
    residence time.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a foam?

A
  • Dispersion of gas within a liquid.
  • Drug dissolved or dispersed in liquid phase.
  • Available as pressurised cans.
  • Foam generated during use and stable only momentarily.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe a spray.

A
  • Aerosol: Dispersion of liquid droplets in gas.
  • Fine mist generated using propellant in pressurised can.
  • Administration without direct skin contact.
  • Rapid and even coverage of large surface area.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe a patch.

A
  • Similar to transdermal patch but for topical delivery.
  • Solid dosage form containing drug on an adhesive film.
  • Discrete dosage unit enables accurate dosing.
  • Provides occlusion, dose retention, and protection of formulation from environmental
    contamination during use.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the advantages of topical preparations?

A
  • Avoid gastrointestinal drug degradation and hepatic first-pass metabolism.
  • Non-invasive, thus well accepted by patients.
  • Better drug targeting, thus minimal systemic side effects.
  • Easy dose withdrawal in case of adverse reactions.
  • Convenient: portable and self-administrable.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the disadvantages of topical preparations?

A
  • Low skin permeability: only a small selection of drugs deliverable, and even then
    their uptake is slow.
  • Skin irritation.
  • Difficult to determine dose accurately (e.g., creams, gels, ointments).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name the cellular layers of the human skin.

A
  • Epidermis
  • Dermis
  • Hypodermis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the stratum conreum of the epidermis.

A
  • Dead cells with a hard protein envelope: the cells contain keratin and are surrounded by lipids
  • It is the permeability barrier
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe dermal drug transport mechanisms.

A
  • Partitioning: from one medium to another, solubility-driven
  • Diffusion: within the same medium down conc. gradient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is skin permeability?

A

A function of the partitioning coefficient and the diffusion coefficient.

Kp = KD/h
Kp = permeability co efficient
K = partition coefficient
D = Diffusion coefficient
h = Diffusion path length

17
Q

Why are transcellular and paracellular pathways important?

A
  • For traditional dosage forms
  • Transcellular route (hydrophilic drugs)
  • Paracellular route (lipophilic drugs)
18
Q

What is the shunt pathway?

A
  • Through hair follicles and sebaceous glands
19
Q

State the factors affecting dermal drug transport.

A
  • Drug properties: lipophilicity, molecular weight
  • Anatomical site: barrier thickness, hair follicle density
  • Age: thickness, hydration, lipid content and microvascular clearance decline with age, corneocytes enlarge with age
  • Disease: broken skin = higher permeability, scaly skin = impaired permeability barrier and dehydrated = reduced permeability
  • Thickened skin = reduced permeability due to increased diffusional path length
20
Q

What is tape stripping?

A
  • Stratum corneum progressively removed by adhesive tape.
  • Drug assayed relative to protein content of the strip.
  • Assumes each tape removes materials from single cellular layer.
  • Tape constituents may contaminate sample.
21
Q

Descibe human skin for in vitro skin models.

A
  • Closest to in vivo human skin.
  • From cadavers or post-operative sources.
  • Requires informed consent and ethical approval.
22
Q

Describe animal skin for in vitro skin models.

A
  • Pig skin closest to human skin anatomically and kinetically.
  • Murine skin cheap and easy to source.
  • Hairless skin models minimise drug transport through follicular pathway.
  • Ethical and legal considerations
23
Q

Descibe artificial membranes for in vitro membranes.

A
  • Alternatives to native biological tissue.
  • Bio-engineered skin equivalents with cellular components, e.g. Episkin™
  • Non-biological polymeric membranes, e.g. Strat-M®
  • Validated through correlation studies using a variety of drugs spanning a range
    of structure, therapeutic classes and physicochemical properties.
  • Cheap, safe, ethical and highly reproducible.